148 related articles for article (PubMed ID: 31034880)
1. Inductively coupled plasma mass spectrometry assay for quantification of free infliximab in serum.
Pavlov IY; Parker RL; Lázár-Molnár E; Strathmann FG; Delgado JC
J Immunol Methods; 2019 Jul; 470():33-39. PubMed ID: 31034880
[TBL] [Abstract][Full Text] [Related]
2. Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
El Amrani M; van den Broek MP; Göbel C; van Maarseveen EM
J Chromatogr A; 2016 Jul; 1454():42-8. PubMed ID: 27264745
[TBL] [Abstract][Full Text] [Related]
3. An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab.
Ternant D; Mulleman D; Degenne D; Willot S; Guillaumin JM; Watier H; Goupille P; Paintaud G
Ther Drug Monit; 2006 Apr; 28(2):169-74. PubMed ID: 16628126
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
El Amrani M; Bosman SM; Egas AC; Hack CE; Huitema ADR; van Maarseveen EM
Ther Drug Monit; 2019 Oct; 41(5):640-647. PubMed ID: 31584927
[TBL] [Abstract][Full Text] [Related]
5. A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study.
Corstjens PL; Fidder HH; Wiesmeijer KC; de Dood CJ; Rispens T; Wolbink GJ; Hommes DW; Tanke HJ
Anal Bioanal Chem; 2013 Sep; 405(23):7367-75. PubMed ID: 23836086
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
Jourdil JF; Némoz B; Gautier-Veyret E; Romero C; Stanke-Labesque F
Ther Drug Monit; 2018 Aug; 40(4):417-424. PubMed ID: 29608486
[TBL] [Abstract][Full Text] [Related]
8. Cold-vapour atomic absorption spectrometry underestimates total mercury in blood and urine compared to inductively-coupled plasma mass spectrometry: an important factor for determining mercury reference intervals.
Chan MH; Chan IH; Kong AP; Osaki R; Cheung RC; Ho CS; Wong GW; Tong PC; Chan JC; Lam CW
Pathology; 2009; 41(5):467-72. PubMed ID: 19900086
[TBL] [Abstract][Full Text] [Related]
9. Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays.
Van Stappen T; Brouwers E; Tops S; Geukens N; Vermeire S; Declerck PJ; Gils A
Ther Drug Monit; 2015 Aug; 37(4):479-85. PubMed ID: 25525757
[TBL] [Abstract][Full Text] [Related]
10. IMPORTANCE OF MEASURING LEVELS OF INFLIXIMAB IN PATIENTS TREATING INFLAMMATORY BOWEL DISEASE IN A BRAZILIAN COHORT.
Kampa KC; Morsoletto DBG; Loures MR; Pissaia A; Nones RB; Ivantes CAP
Arq Gastroenterol; 2017 Dec; 54(4):333-337. PubMed ID: 28954041
[TBL] [Abstract][Full Text] [Related]
11. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
[TBL] [Abstract][Full Text] [Related]
12. Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.
Barclay ML; Karim S; Helms ETJ; Keating PE; Hock B; Stamp LK; Schultz M
Intern Med J; 2019 Apr; 49(4):513-518. PubMed ID: 30091273
[TBL] [Abstract][Full Text] [Related]
13. Lanthanide polymer labels for multiplexed determination of biomarkers in human serum samples by means of size exclusion chromatography-inductively coupled plasma mass spectrometry.
Pérez E; Bierla K; Grindlay G; Szpunar J; Mora J; Lobinski R
Anal Chim Acta; 2018 Aug; 1018():7-15. PubMed ID: 29605136
[TBL] [Abstract][Full Text] [Related]
14. High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers.
Van Acker T; Buckle T; Van Malderen SJM; van Willigen DM; van Unen V; van Leeuwen FWB; Vanhaecke F
Anal Chim Acta; 2019 Oct; 1074():43-53. PubMed ID: 31159938
[TBL] [Abstract][Full Text] [Related]
15. DNA quantification via ICP-MS using lanthanide-labeled probes and ligation-mediated amplification.
Brückner K; Schwarz K; Beck S; Linscheid MW
Anal Chem; 2014 Jan; 86(1):585-91. PubMed ID: 24215636
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of motexafin lutetium in human plasma by liquid chromatography-tandem mass spectrometry and inductively coupled plasma-atomic emission spectroscopy.
Miles D; Mody TD; Hatcher LI; Fiene J; Stiles M; Lin PP; Lee JW
AAPS PharmSci; 2003; 5(3):E23. PubMed ID: 14621958
[TBL] [Abstract][Full Text] [Related]
17. SERUM INFLIXIMAB MEASUREMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION: A COMPARATIVE ANALYSIS OF TWO DIFFERENT METHODS IN A MULTICENTRIC BRAZILIAN COHORT.
Teixeira FV; Sassaki LY; Saad-Hossne R; Baima JP; Magro DO; Coy CSR; Kotze PG
Arq Gastroenterol; 2018; 55(2):192-197. PubMed ID: 30043873
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of a microwave-assisted metal-labeling strategy for quantification of peptides via RPLC-ICP-MS and the method of standard additions.
Christopher SJ; Kilpatrick EL; Yu LL; Davis WC; Adair BM
Talanta; 2012 Jan; 88():749-58. PubMed ID: 22265570
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum.
Wang SL; Ohrmund L; Hauenstein S; Salbato J; Reddy R; Monk P; Lockton S; Ling N; Singh S
J Immunol Methods; 2012 Aug; 382(1-2):177-88. PubMed ID: 22691619
[TBL] [Abstract][Full Text] [Related]
20. A method for studies on interactions between a gold-based drug and plasma proteins based on capillary electrophoresis with inductively coupled plasma mass spectrometry detection.
Nguyen TT; Østergaard J; Gammelgaard B
Anal Bioanal Chem; 2015 Nov; 407(28):8497-503. PubMed ID: 26329282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
